Remnant-like particles and coronary artery disease in familial hypercholesterolemia.
暂无分享,去创建一个
K. Hayashi | M. Yamagishi | H. Mabuchi | A. Nohara | M. Kawashiri | Akihiro Inazu | H. Tada | K. Sakata
[1] M. Yamagishi,et al. Impact of clinical signs and genetic diagnosis of familial hypercholesterolaemia on the prevalence of coronary artery disease in patients with severe hypercholesterolaemia , 2017, European heart journal.
[2] G. Watts,et al. Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study) , 2017, Circulation.
[3] S. Humphries,et al. Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel. , 2016, The lancet. Diabetes & endocrinology.
[4] K. Hayashi,et al. Lipoprotein(a) in Familial Hypercholesterolemia With Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Gain-of-Function Mutations. , 2016, Circulation journal : official journal of the Japanese Circulation Society.
[5] R. Dufour,et al. PCSK9 R46L, Lower LDL, and Cardiovascular Disease Risk in Familial Hypercholesterolemia: A Cross-Sectional Cohort Study , 2014, Arteriosclerosis, thrombosis, and vascular biology.
[6] Takamitsu Nakamura,et al. High remnant lipoprotein predicts recurrent cardiovascular events on statin treatment after acute coronary syndrome. , 2014, Circulation journal : official journal of the Japanese Circulation Society.
[7] B. Nordestgaard,et al. Remnant cholesterol and ischemic heart disease , 2014, Current opinion in lipidology.
[8] K. Hayashi,et al. Post‐prandial remnant lipoprotein metabolism in autosomal recessive hypercholesterolaemia , 2012, European journal of clinical investigation.
[9] K. Hayashi,et al. Altered Metabolism of Low-Density Lipoprotein and Very-Low-Density Lipoprotein Remnant in Autosomal Recessive Hypercholesterolemia: Results From Stable Isotope Kinetic Study In Vivo , 2012, Circulation. Cardiovascular genetics.
[10] Kohjiro Ueki,et al. Report of the Committee on the Classification and Diagnostic Criteria of Diabetes Mellitus , 2010, Journal of diabetes investigation.
[11] A. Soutar,et al. Mechanisms of Disease: genetic causes of familial hypercholesterolemia , 2007, Nature Clinical Practice Cardiovascular Medicine.
[12] G. Nakazawa,et al. Prevalence of Carotid Artery Stenosis in Patients With Coronary Artery Disease in Japanese Population , 2005, Stroke.
[13] K. Kugiyama,et al. Prognostic value of remnant-like lipoprotein particle levels in patients with coronary artery disease and type II diabetes mellitus. , 2004, Journal of the American College of Cardiology.
[14] J J Kastelein,et al. Mortality over two centuries in large pedigree with familial hypercholesterolaemia: family tree mortality study. , 2001, BMJ : British Medical Journal.
[15] H Yasue,et al. Remnant lipoprotein levels in fasting serum predict coronary events in patients with coronary artery disease. , 1999, Circulation.
[16] S. Kihara,et al. Familial hypercholesterolemia. , 2014, Journal of atherosclerosis and thrombosis.
[17] T. Farag. Familial hypercholesterolemia. , 1988, Journal of the Royal Society of Medicine.